Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

Friis-Moller, 2007, Class of antiretroviral drugs and the risk of myocardial infarction, N Engl J Med, 356, 1723, 10.1056/NEJMoa062744

Sabin, 2008, Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration, Lancet, 371, 1417, 10.1016/S0140-6736(08)60423-7

Podzamczer, 2007, Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study, J Acquir Immune Defic Syndr, 44, 139, 10.1097/QAI.0b013e31802bf122

Jones, 2005, Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone, HIV Med, 6, 396, 10.1111/j.1468-1293.2005.00325.x

Anastos, 2007, Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens, J Acquir Immune Defic Syndr, 45, 34, 10.1097/QAI.0b013e318042d5fe

Gokce, 2003, Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease, J Am Coll Cardiol, 41, 1769, 10.1016/S0735-1097(03)00333-4

Neunteufl, 2000, Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain, Am J Cardiol, 86, 207, 10.1016/S0002-9149(00)00857-2

Ganz, 2003, Testing endothelial vasomotor function: nitric oxide, a multipotent molecule, Circulation, 108, 2049, 10.1161/01.CIR.0000089507.19675.F9

Lerman, 2005, Endothelial function: cardiac events, Circulation, 111, 363, 10.1161/01.CIR.0000153339.27064.14

Torriani, 2008, Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s, J Am Coll Cardiol, 52, 569, 10.1016/j.jacc.2008.04.049

Prasad, 2002, Predisposition to atherosclerosis by infections: role of endothelial dysfunction, Circulation, 106, 184, 10.1161/01.CIR.0000021125.83697.21

Corretti, 2002, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force, J Am Coll Cardiol, 39, 257, 10.1016/S0735-1097(01)01746-6

Kinlay, 2004, Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function, J Am Coll Cardiol, 43, 629, 10.1016/j.jacc.2003.08.051

Lieberman, 1996, Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease, Am J Cardiol, 78, 1210, 10.1016/S0002-9149(96)00597-8

Stadler, 1996, New methods for arterial diameter measurement from B-mode images, Ultrasound Med Biol, 22, 25, 10.1016/0301-5629(95)02017-9

Nohria, 2006, Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease, Circ Res, 99, 1426, 10.1161/01.RES.0000251668.39526.c7

Hsue, 2004, Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection, Circulation, 109, 1603, 10.1161/01.CIR.0000124480.32233.8A

Lorenz, 2008, Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis, Atherosclerosis, 196, 720, 10.1016/j.atherosclerosis.2006.12.022

Triant, 2007, Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease, J Clin Endocrinol Metab, 92, 2506, 10.1210/jc.2006-2190

Hsue, 2006, Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses, AIDS, 20, 2275, 10.1097/QAD.0b013e3280108704

Friis-Moller, 2003, Combination antiretroviral therapy and the risk of myocardial infarction, N Engl J Med, 349, 1993, 10.1056/NEJMoa030218

Brothers, 2009, Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects, J Acquir Immune Defic Syndr, 51, 20, 10.1097/QAI.0b013e31819ff0e6

Verma, 2002, Fundamentals of endothelial function for the clinical cardiologist, Circulation, 105, 546, 10.1161/hc0502.104540

Gokce, 2002, Clinical manifestations of endothelial dysfunction, 685

Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353

Widlansky, 2003, The clinical implications of endothelial dysfunction, J Am Coll Cardiol, 42, 1149, 10.1016/S0735-1097(03)00994-X

Jin, 2005, Endogenous mechanisms of inhibition of platelet function, Microcirculation, 12, 247, 10.1080/10739680590925493

Freedman, 1997, Nitric oxide released from activated platelets inhibits platelet recruitment, J Clin Invest, 100, 350, 10.1172/JCI119540

Ruggeri, 2007, Adhesion mechanisms in platelet function, Circ Res, 100, 1673, 10.1161/01.RES.0000267878.97021.ab

Yeboah, 2007, Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study, Circulation, 115, 2390, 10.1161/CIRCULATIONAHA.106.678276

Mohiaddin, 2004, Glagov remodeling of the atherosclerotic aorta demonstrated by cardiovascular magnetic resonance: the CORDA asymptomatic subject plaque assessment research (CASPAR) project, J Cardiovasc Magn Reson, 6, 517, 10.1081/JCMR-120030576

van Vonderen, 2009, Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy, J Infect Dis, 199, 1186, 10.1086/597475